Therefore, we systematically research the pathological function and molecular mechanism of OSBPL2 with Collagen-I in CRC development and therapies of ERK and PARP1 inhibitors for OSBPL2 loss. This evidence concerns the gene OSBPL2 and colorectal carcinoma.